{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-22-007975","form_type":"8-K","ticker":"HBIO","cik":"0001123494","company_name":"HARVARD BIOSCIENCE INC","filed_at":"2022-12-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:49.672567+00:00","generated_at":"2026-06-21T05:57:12.540050+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Harvard Bioscience CFO Michael Rossi resigns; Jennifer Cote named interim CFO","bullets":["Michael Rossi resigns as CFO and Treasurer effective Dec 31, 2022; will provide transition assistance through May 10, 2023.","Jennifer Cote, VP of Global Finance since May 2022, appointed Interim CFO and Treasurer effective upon Rossi's departure.","Cote previously held finance leadership roles at Bose Corporation and Arthur Andersen; is a CPA and CGMA.","Company has initiated a search for a permanent CFO to succeed Rossi."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-22-007975","json":"https://secwatch.observer/filing/0001171843-22-007975.json","markdown":"https://secwatch.observer/filing/0001171843-22-007975.md","text":"https://secwatch.observer/filing/0001171843-22-007975.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1123494/000117184322007975/0001171843-22-007975-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1123494/000117184322007975/f8k_120922.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T05:57:12.540050+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"11dafc85a8","claim":"Jennifer Cote was appointed as Interim Chief Financial Officer and Treasurer at HARVARD BIOSCIENCE INC.","evidence_excerpt":"On December 8, 2022, the Company appointed Jennifer Cote to serve as Interim Chief Financial Officer and Treasurer effective upon Mr. Rossi’s resignation.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1123494/000117184322007975/0001171843-22-007975-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Financial Officer and Treasurer"}],"fact_type":"executive_change"},{"claim_id":"57eae000de","claim":"Michael Rossi resigned as Chief Financial Officer and Treasurer at HARVARD BIOSCIENCE INC.","evidence_excerpt":"On December 7, 2022, Michael Rossi notified Harvard Bioscience, Inc. (the “Company”) of his resignation as Chief Financial Officer and Treasurer, effective December 31, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1123494/000117184322007975/0001171843-22-007975-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer and Treasurer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}